Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tigger transposable element derived 1 pseudogene (TIGD1P (not commonly in use; TIGD1 is used for the protein-coding gene—this entry is a pseudogene))
- Target
- TIGD1P (not commonly in use; TIGD1 is used for the protein-coding gene—this entry is a pseudogene)
- Molecular classification
- Pseudogene, Transposable element-derived, Other (not a receptor, enzyme, transporter, etc.)
01
Overview
The Tigger transposable element derived 1 pseudogene (ENSG00000250422) is a genomic sequence in humans derived from the inactive Tigger subfamily of DNA transposons, classified as a pseudogene. Unlike functional protein-coding genes, pseudogenes such as this one do not produce active proteins and have lost their original transposase function due to mutations and sequence deterioration over evolutionary time. Tigger elements were once part of the active transposon landscape in mammals but have been extinct for at least 40 million years[1][6]. This locus represents a molecular fossil, present as a result of gene non-functionalization and genomic rearrangement[2][6]. It is not implicated as a receptor, enzyme, transporter, or transcription factor, and current knowledge indicates no role in disease or therapy. The pseudogenization of transposon-derived genes is common and reflects evolutionary processes that limit transposon mobility and maintain genome integrity[2][4][6]. The protein-coding gene TIGD1, related but distinct (ENSG00000221944), has some reported disease associations, but no evidence supports functional or therapeutic significance for the pseudogene[3].
- Other names
- Tigger transposable element derived 1 pseudogeneTIGD1 pseudogene
02
Mechanism of action
None applicable; pseudogenes are not targeted by drugs.
03
Biological functions
None. Pseudogenes do not encode functional proteins; they are often considered genomic fossils. Rarely, pseudogenes may influence gene regulation, usually through noncoding RNA effects, but there is no specific evidence for this locus
04
Disease associations
Other. No validated disease association; some TIGD1 family pseudogenes may be considered in studies of genome evolution, but not in pathology or therapy
05
Safety considerations
None directly. As a pseudogene, TIGD1P has no therapeutic or experimental manipulation effects documented in the literature
06
Interacting drugs
None. Pseudogenes are not known drug targets
07
Biomarkers
None established for patient selection or monitoring; TIGD1 family pseudogenes are not used clinically as biomarkers
Beyond the preview
Go deeper on Tigger transposable element derived 1 pseudogene (TIGD1P (not commonly in use; TIGD1 is used for the protein-coding gene—this entry is a pseudogene)).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tigger transposable element derived 1 pseudogene (TIGD1P (not commonly in use; TIGD1 is used for the protein-coding gene—this entry is a pseudogene)).